---
figid: PMC7917650__cells-10-00383-g002
figlink: pmc/articles/PMC7917650/figure/cells-10-00383-f002/
number: Figure 2
caption: '(A) Balanced agonism. Binding of IGF-I to the IGF-IR induces stimulates
  both the β-arrestin-1 pathway that leads to MAPK activation and proteasome degradation
  of the IGF-IR through an ubiquitin-mediated mechanism resulting in a loss of the
  number of IGF-IRs at cellular membrane. IGF-I binding to the IGF-IR also induces
  phosphorylation of tyrosine residues and this stimulates the kinase pathway which
  finally activates AKT. (B) β-arrestin-1-biased agonism. Binding of a biased agonist
  preferentially increases β-arrestin-1 signaling and this simultaneously inhibits
  the IGF-IR kinase pathway. Thus, β-arrestin-1-biased agonism results in down-regulation
  of the IGF-IR and inhibition of AKT signaling, but increases MAPK-mediated cell
  proliferation and growth (Modified from Salisbury & Tomblin. Insulin/Insulin-like
  growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance
  mechanisms, and new blocking strategies [].'
pmcid: PMC7917650
papertitle: Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy.
reftext: Joseph A.M.J.L. Janssen, et al. Cells. 2021 Feb;10(2):383.
pmc_ranked_result_index: '9836'
pathway_score: 0.9601334
filename: cells-10-00383-g002.jpg
figtitle: ' Balanced agonism'
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7917650__cells-10-00383-g002.html
  '@type': Dataset
  description: '(A) Balanced agonism. Binding of IGF-I to the IGF-IR induces stimulates
    both the β-arrestin-1 pathway that leads to MAPK activation and proteasome degradation
    of the IGF-IR through an ubiquitin-mediated mechanism resulting in a loss of the
    number of IGF-IRs at cellular membrane. IGF-I binding to the IGF-IR also induces
    phosphorylation of tyrosine residues and this stimulates the kinase pathway which
    finally activates AKT. (B) β-arrestin-1-biased agonism. Binding of a biased agonist
    preferentially increases β-arrestin-1 signaling and this simultaneously inhibits
    the IGF-IR kinase pathway. Thus, β-arrestin-1-biased agonism results in down-regulation
    of the IGF-IR and inhibition of AKT signaling, but increases MAPK-mediated cell
    proliferation and growth (Modified from Salisbury & Tomblin. Insulin/Insulin-like
    growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance
    mechanisms, and new blocking strategies [].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - IGF1R
  - AKT2
  - AKT3
  - AKT1
genes:
- word: IGF-I
  symbol: IGF-I
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IGF-I
  symbol: IGF-I
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IGF-I
  symbol: IGF-I
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
chemicals: []
diseases: []
---
